Cardiac Computed Tomography: Characteristics of Isolated Left Ventricular Non-compaction
1 other identifier
observational
39
1 country
1
Brief Summary
The diagnostic criteria for isolated left ventricular non-compaction cardiomyopathy (IVNC) have been well established for echocardiography and cardiac magnetic resonance, such validation is lacking for computed tomography (CT). Such criteria are of great clinical relevance as a growing number of patients undergo a cardiac CT scan in daily clinical routine. The investigators aim to test the diagnostic accuracy of cardiac CT in distinguishing IVNC from lesser degrees of trabecular layering seen in potential differential diagnoses such as cardiomyopathies and left ventricular hypertrophy or dilation. The investigators hypothesize that echocardiographic diagnosed pathological trabeculation can be distinguished by determining the ratio of non-compacted to compacted myocardium on cardiac CT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 27, 2011
CompletedFirst Posted
Study publicly available on registry
November 10, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedDecember 10, 2015
December 1, 2015
3.2 years
October 27, 2011
December 9, 2015
Conditions
Keywords
Study Arms (2)
IVNC
differential diagnosis to IVNC
Eligibility Criteria
Patients will be recruited from the Department of Cardiology and Cardiac Imaging Division. They will be asked if they want to participate in this study.
You may qualify if:
- Established diagnosis of IVNC or differential diagnosis
- Age: Men \> 30 years, women \> 50 years without menstruation for at least 2 month.
- Written informed consent to participate
You may not qualify if:
- Renal insufficiency (GFR \< 60ml/min)
- Known allergy to iodinated contrast agent
- Known Hyperthyroidism
- Non-sinus rhythm
- Known premature ventricular or supraventricular beats
- Hypotension (systolic blood pressure \< 100mmHg)
- Contraindication for CMR
- Implanted cardiac pacemaker or defibrillator
- Other implanted medical devices (e.g. implantable cardioverter-defibrillator)
- Claustrophobia
- Known premature ventricular or supraventricular beats
- Pregnancy
- Claustrophobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unknown Facility
Zurich, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Felix Tanner, Prof. MD
University Hospital Zurich, Division of Cardiology
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 27, 2011
First Posted
November 10, 2011
Study Start
October 1, 2011
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
December 10, 2015
Record last verified: 2015-12